Skip to main content
. Author manuscript; available in PMC: 2023 Jun 5.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2022 Dec 5;31(12):2185–2191. doi: 10.1158/1055-9965.EPI-22-0548

Table 2.

Anal Cytology and Anal HPV Testing

Cervix (N=250) Vagina (N=28) Vulva (N=46) Total (N=324) P-value

Anal Cytology Result, n (%) >0.991
 Normal 177 (77%) 22 (79%) 34 (77%) 233 (77%)
 Abnormal 54 (23%) 6 (21%) 10 (23%) 70 (23%)
 Insufficient 6 0 1 7
 Missing 13 0 1 14
Abnormal Anal Cytology Result, n (%) 0.7301
 ASCUS 42 (78%) 4 (67%) 9 (90%) 55 (79%)
 LSIL/AIN 1 5 (9%) 1 (17%) 0 (0%) 6 (9%)
 HSIL/AIN 2–3 1 (2%) 0 (0%) 0 (0%) 1 (1%)
 ASC-H 6 (11%) 1 (17%) 1 (10%) 8 (11%)
Anal HPV Testing Result, n (%) 0.5321
 Total hrHPV Positive 70 (32%) 6 (24%) 16 (37%) 92 (32%)
 Total hrHPV Negative 149 (68%) 19 (76%) 27 (63%) 195 (68%)
 Insufficient 30 3 2 35
 Missing 1 0 1 2
1

Fisher Exact p-value

NOTE: Percentages may not sum to 100% due to rounding